OS
OSCR.US Oscar Health Inc
- Market cap
- USD 9.65B
- P/E
- 13.8x
- P/B
- 4.34x
- ROE
- 72.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is OSCR.US undervalued?
Graham numberOSCR.US trades 63.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Oscar Health Inc fundamental analysis
No fundamental analysis for Oscar Health Inc yet.
Oscar Health Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Oscar Health Inc
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and con…
Full company profileOscar Health Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Oscar Health Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 554M | 590M | 1.92B | 4.13B | 5.86B | 9.18B | 11.7B | 19.6B |
| Gross Profit | 554M | 590M | 1.92B | 4.13B | 5.86B | 1.84B | 1.68B | 9.61B |
| Operating Income | -259M | -406M | -571M | -610M | -236M | 57.3M | -396M | 1.69B |
| EBITDA | -252M | -391M | -551M | -572M | -236M | 89.3M | -391M | 1.72B |
| Net Income | -261M | -407M | -573M | -606M | -271M | 25.4M | -443M | 1.61B |
| EPS | -9.06 | -14 | -3.20 | -2.85 | -1.22 | 0.10 | -1.69 | 4.65 |
| Balance Sheet | ||||||||
| Total Assets | 1.35B | 2.27B | 3.32B | 4.53B | 3.60B | 4.84B | 6.33B | 10.0B |
| Total Liabilities | 494M | 3.57B | 1.93B | 3.63B | 2.80B | 3.82B | 5.34B | 7.78B |
| Shareholders' Equity | 853M | -1.30B | 1.39B | 890M | 804M | 1.01B | 978M | 2.22B |
| Cash & Short-term Investments | 670M | 1.19B | 1.69B | 2.96B | 2.56B | 2.15B | 3.99B | 7.49B |
| Total Debt | - | 142M | 297M | 298M | 299M | 300M | 430M | 432M |
| Cash Flow | ||||||||
| Operating Cash Flow | -165M | 223M | -182M | 380M | -272M | 978M | 1.09B | 4.62B |
| Capital Expenditure | 26.0M | 14.0M | 25.9M | 29.0M | 25.6M | 27.9M | 36.4M | 42.5M |
| Free Cash Flow | -191M | 209M | -208M | 351M | -298M | 950M | 1.06B | 4.58B |
| Ratios | ||||||||
| ROE | -30.6% | - | -41.3% | -68.1% | -33.7% | 2.5% | -45.3% | 72.5% |
| ROA | -19.4% | -17.9% | -17.2% | -13.4% | -7.5% | 0.5% | -7.0% | 16.1% |
| Net Profit Margin | -47.2% | -69.0% | -29.8% | -14.7% | -4.6% | 0.3% | -3.8% | 8.2% |
| Debt to Equity | - | - | 0.21x | 0.33x | 0.37x | 0.30x | 0.44x | 0.19x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Oscar Health Inc dividends
Oscar Health Inc has not paid dividends in the last 7 fiscal years.
Who owns Oscar Health Inc
- Insiders 5.90%
- Institutions 72.44%
- Public & others 21.66%
- Shares outstanding 276M
- Free float 266M
Top funds holding OSCR.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 7.82M | 2.52% | +2.65% | Sep 2026 |
| iShares Russell 2000 ETF | 6.11M | 1.97% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 5.54M | 1.78% | +0.55% | Sep 2026 |
| Avantis US Small Cap Value ETF | 4.66M | 1.50% | 0.00% | Oct 2026 |
| Vanguard MStar Small Cap Growth Indx Inv | 3.09M | 0.99% | -2.37% | Sep 2026 |
| T. Rowe Price Small-Cap Stock | 2.96M | 0.95% | -0.57% | Sep 2026 |
| Fidelity Small Cap Index | 2.64M | 0.85% | +0.15% | Aug 2026 |
| Fidelity Small Cap Growth | 2.43M | 0.78% | +4.63% | Aug 2026 |
| iShares Russell 2000 Growth ETF | 2.27M | 0.73% | -0.38% | Oct 2026 |
| BIT Global Technology Leaders R-I | 2.08M | 0.67% | -18.91% | Jul 2026 |
| T. Rowe Price US Smlr Coms Eq A | 1.99M | 0.64% | -3.07% | Oct 2026 |
| T. Rowe Price Small-Cap Value | 1.91M | 0.61% | 0.00% | Sep 2026 |
| Fidelity Enhanced Small Cap Core ETF | 1.61M | 0.52% | +0.27% | Oct 2026 |
| T. Rowe Price Instl Small-Cap Stock | 1.59M | 0.51% | -1.89% | Sep 2026 |
| Avantis US Large Cap Value ETF | 1.50M | 0.48% | +0.10% | Oct 2026 |
| Vanguard Russell 2000 ETF | 1.40M | 0.45% | +1.13% | Sep 2026 |
| Schwab US Small-Cap ETF™ | 1.35M | 0.43% | +0.24% | Oct 2026 |
| Fidelity Small Cap Growth K6 | 1.27M | 0.41% | +4.63% | Aug 2026 |
| Fidelity Extended Market Index | 1.17M | 0.38% | +8.50% | Sep 2026 |
| T. Rowe Price Integrated US Sm Gr Eq | 1.06M | 0.34% | 0.00% | Sep 2026 |
Top institutions holding OSCR.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 20.6M | 6.63% | +18.94% | Jun 2026 |
| T. Rowe Price Investment Management,Inc. | 13.0M | 4.20% | +11.95% | Jun 2026 |
| D. E. Shaw & Co LP | 12.6M | 4.07% | +130.50% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 11.0M | 3.55% | +4.59% | Jun 2026 |
| Vanguard Capital Management, LLC | 10.6M | 3.41% | -1.84% | Jun 2026 |
| American Century Companies Inc | 8.53M | 2.74% | -5.83% | Sep 2026 |
| Jane Street Group LLC | 6.37M | 2.05% | +119.17% | Jun 2026 |
| Thrive Capital Management, LLC(NY) | 6.34M | 2.04% | 0.00% | Jun 2026 |
| Geode Capital Management, LLC | 5.82M | 1.87% | +15.64% | Jun 2026 |
| State Street Corp | 5.80M | 1.87% | +10.24% | Jun 2026 |
| FMR Inc | 5.00M | 1.61% | +316.97% | Jun 2026 |
| Citadel Advisors Llc | 4.23M | 1.36% | +22.02% | Jun 2026 |
| Two Sigma Investments LLC | 4.04M | 1.30% | +71.77% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 3.90M | 1.26% | +9.24% | Sep 2026 |
| Renaissance Technologies Corp | 3.85M | 1.24% | +17.15% | Sep 2026 |
| T. Rowe Price Associates, Inc. | 3.26M | 1.05% | +70.11% | Jun 2026 |
| Jacobs Levy Equity Management, Inc. | 3.03M | 0.97% | +22.26% | Jun 2026 |
| Glynn Capital Management, LLC | 2.58M | 0.83% | -0.62% | Jun 2026 |
| Assenagon Asset Management SA | 2.50M | 0.80% | +103.29% | Jun 2026 |
| The Goldman Sachs Group Inc | 2.29M | 0.74% | +55.57% | Jun 2026 |
Oscar Health Inc company profile
- Company name
- Oscar Health Inc
- Ticker
- OSCR.US
- Exchange
- USA Stocks
- Listed since
- Mar 3, 2021
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 2,305
- Fiscal year end
- December
- Address
- 75 Varick Street, New York, NY, United States, 10013
- Phone
- 646 403 3677
- Website
- hioscar.com
About Oscar Health Inc
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Oscar Health Inc management
10- Mr. Mark Thomas BertoliniCEO & Director · born 1957
- Mr. Joshua KushnerCo-Founder & Vice Chairman · born 1985
- Mr. Mario Tobias SchlosserCo-Founder, Advisor to the CEO & Director · born 1979
- Mr. Richard Scott Blackley CPAChief Financial Officer · born 1968
- Mr. Adam McAnaneyEVP & Chief Legal Officer · born 1977
- Ms. Janet Ann LiangEVP & President of Oscar Insurance · born 1968
- Ms. Victoria BaltrusChief Accounting Officer · born 1970
- Chris PotocharVice President of Treasury & Investor Relations
- Ms. Rebecca KrouseChief People Officer
- Mr. Joel I. Klein J.D.Senior Advisor · born 1947